Latest Regulatory Risk News

AuMEGA Metals Limited has launched a prospectus for a dual-tranche capital raising totalling approximately C$23.7 million, subject to shareholder approval, aimed at advancing its exploration programs in Newfoundland and Labrador, Canada.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.

Energy Transition Minerals Ltd (ETM) confronts unexpected uncertainty as Greenlandic authorities signal potential non-extension of the Kvanefjeld exploration licence, disrupting planned 2026 activities and intensifying ongoing legal disputes.

The Australian Treasurer has issued interim directions preventing Hong Kong Ying Tak Limited from transferring or voting over 361 million shares in Northern Minerals, amid suspected breaches of foreign investment disposal orders. Northern Minerals is cooperating with regulators while focusing on its rare earths project.

Count Limited has successfully raised $35.9 million through an institutional placement to partially fund its acquisition of Oracle Group Ltd, while also launching a $5 million Share Purchase Plan for existing shareholders.

Fiducian Investment Management Services Limited has reached a heads of agreement with ASIC to resolve civil proceedings over misleading disclosures in its Diversified Social Aspirations Fund. The settlement includes a $7.3 million penalty and legal costs, pending court approval.

Kjerulf David Hastings Ainsworth has initiated a second unconditional off-market takeover bid for 5.5% of Ainsworth Game Technology shares at a significant premium, aiming to increase his stake and influence in the company.

AdAlta’s subsidiary AdCella has completed its first Joint Development Committee meeting with Shanghai Cell Therapy Group, advancing the development of the CAR-T therapy BZDS1901 with potential timeline acceleration and reduced regulatory risks.

Reach Resources Limited has announced a pro-rata entitlement issue aiming to raise up to $3.15 million to fund exploration and working capital, with key directors and the CEO committing to participate.

Manuka Resources has released an amended Pre-Feasibility Study for its Cobar Basin assets, revealing a significant uplift in project profitability and a detailed 10-year mine plan targeting production in Q2 2026.

Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.